Trials / Completed
CompletedNCT05406778
The REMIND Study- SPARK Neuro Software Study
SPARK Neuro Quantitative Resting State EEG Protocol for Assessing Cognitive Impairment and Alzheimer's Disease Status- The REMIND Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 185 (actual)
- Sponsor
- Spark Neuro Inc. · Industry
- Sex
- All
- Age
- 55 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The study utilizes investigational software, the SPARK Test, with an FDA-cleared electroencephalography (EEG) amplifier and EEG cap to collect and patient EEG data.
Detailed description
The aim of this study is to collect data to support development of an algorithm to determine whether applying machine-learning techniques to eyes open/eyes closed resting-state electroencephalography (EEG) can characterize patient's cognitive status and detect the presence or absence of AD on the basis of the patient's EEG.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SPARK Test | Thirty (30) minutes of resting state EEG data collection. |
Timeline
- Start date
- 2022-05-18
- Primary completion
- 2023-08-24
- Completion
- 2024-01-19
- First posted
- 2022-06-06
- Last updated
- 2025-08-14
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05406778. Inclusion in this directory is not an endorsement.